|
Daily Medical Update
Thyroid nodules and thyroid cancer
Tuesday, September 22, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Endocrine pathology (2026) - Meta-Analysis
Key Findings
- Conventional management had significantly higher surgical rates than molecular testing (OR 2.258, 95% CI 1.548-3.293).
- First-generation tests had higher surgical rates and lower resected-nodule malignancy rates than second-generation assays; molecular testing did not show reduced detection of clinically significant malignancy.
📋 Practice Implication: For Bethesda III/IV nodules, second-generation molecular testing can support more selective surgery, while interpretation should account for how noninvasive lesions are classified.
|
Frontiers in endocrinology (2026) - Meta-Analysis
Key Findings
- Male sex, family history of thyroid cancer, higher thyroid-stimulating hormone, hypoechogenicity, solid composition, calcifications, taller-than-wide shape, and irregular margins were associated with increased odds of malignancy.
- Increasing age and larger nodule size showed inverse associations, although between-study heterogeneity was substantial.
📋 Practice Implication: Pre-biopsy assessment should combine patient-level risk factors with ultrasound phenotype rather than relying on nodule size or age alone.
|
Human pathology (2026) - Meta-Analysis
Key Findings
- Invasive malignancy occurred in 28 of 87 resected PTEN-altered nodules (32.2%).
- Pooled invasive malignancy risk was 32.4% (95% CI 23.4%-42.9%); counting NIFTP as an event increased the estimate to 37.7%.
📋 Practice Implication: A PTEN alteration should be communicated as an intermediate-risk result and integrated with cytology, imaging, morphology, and clinical context before surgery is chosen.
|
Thyroid : official journal of the American Thyroid Association (2026) - Meta-Analysis
Key Findings
- The pooled progression rate during active surveillance was 23% (95% CI 12%-34%) overall and 32% (95% CI 15%-55%) in biopsy-confirmed cases.
- Progression was more frequent with shorter follow-up and advanced stage, while adjustment for follow-up loss increased the estimated pooled rate to 35%-70%; baseline thyroglobulin was higher in the progression group.
📋 Practice Implication: Active surveillance may suit carefully selected locoregional recurrences, but elevated thyroglobulin, advanced stage, and incomplete follow-up warrant closer monitoring or earlier intervention.
|
Head & neck (2026) - Meta-Analysis
Key Findings
- Multifocality occurred in 30.7% of pediatric cases, extrathyroidal extension in 45.4%, and lateral neck lymph-node metastasis in 51.6%.
- Multifocality and extrathyroidal extension predicted worse disease-free survival (HR 1.86 and 1.78, respectively), whereas lateral neck lymph-node metastasis was not a reliable predictor (HR 1.77, p = 0.161).
📋 Practice Implication: Pediatric recurrence planning should give particular weight to multifocality and extrathyroidal extension, while treating lateral nodal involvement as a less consistent standalone prognostic marker.
|
|
💡
Summary
Five high-significance meta-analyses refine risk stratification and treatment decisions across thyroid nodules and cancer. Molecular testing was associated with fewer surgeries for indeterminate nodules, while PTEN alterations carried an intermediate invasive malignancy risk of about 32%. Active surveillance for locoregional recurrent differentiated thyroid cancer had a 23% pooled progression rate, and pediatric recurrence risk was most clearly associated with multifocality and extrathyroidal extension.
|
|